» Articles » PMID: 25841311

Incidence of Bisphosphonate-related Osteonecrosis of the Jaw in High-risk Patients Undergoing Surgical Tooth Extraction

Overview
Publisher Elsevier
Date 2015 Apr 6
PMID 25841311
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

As the most suitable approach for preventing bisphosphonate-related osteonecrosis of the jaw (BRONJ) in patients undergoing surgical tooth extraction is still under discussion, the present study evaluates the incidence of BRONJ after surgical tooth extraction using a standardized surgical protocol in combination with an adjuvant perioperative treatment setting in patients who are at high-risk for developing BRONJ. High-risk patients were defined as patients who received intravenous bisphosphonate (BP) due to a malignant disease. All teeth were removed using a standardized surgical protocol. The perioperative adjuvant treatment included intravenous antibiotic prophylaxis starting at least 24 h before surgery, a gastric feeding tube and mouth rinses with chlorhexidine (0.12%) three times a day. In the follow-up period patients were examined every 4 weeks for the development of BRONJ. Minimum follow-up was 12 weeks. In 61 patients a total number of 184 teeth were removed from 102 separate extraction sites. In eight patients (13.1%) BRONJ developed during the follow-up. A higher risk for developing BRONJ was found in patients where an additional osteotomy was necessary (21.4% vs. 8.0%; p = 0.0577), especially for an osteotomy of the mandible (33.3% vs. 7.3%; p = 0.0268). Parameters including duration of intravenous antibiotic prophylaxis, the use of a gastric feeding tube and the duration of intravenous BP therapy showed no statistical impact on the development of BRONJ. Furthermore, patients currently undergoing intravenous BP therapy showed no higher risk for BRONJ compared with patients who have paused or completed their intravenous BP therapy (p = 0.4232). This study presents a protocol for surgical tooth extraction in high-risk BP patients in combination with a perioperative adjuvant treatment setting, which reduced the risk for postoperative BRONJ to a minimum. However, the risk for BRONJ increases significantly if an additional osteotomy is necessary, especially in the mandible.

Citing Articles

Prevalence and Factors Influencing Post-Operative Complications following Tooth Extraction: A Narrative Review.

Dignam P, Elshafey M, Jeganathan A, Foo M, Park J, Ratnaweera M Int J Dent. 2024; 2024:7712829.

PMID: 38756385 PMC: 11098612. DOI: 10.1155/2024/7712829.


Is withdrawal of antiresorptive agents necessary before and after tooth extraction? A systematic review.

Takeda D, Kurita H, Kashima Y, Hasegawa T, Miyakoshi M, Yamada S Clin Oral Investig. 2023; 28(1):38.

PMID: 38150155 DOI: 10.1007/s00784-023-05462-9.


Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws.

Lee E, Tsai M, Lee J, Wong C, Cheng Y, Liu A Cancers (Basel). 2023; 15(22).

PMID: 38001626 PMC: 10670230. DOI: 10.3390/cancers15225366.


Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP).

Landi L, Leali P, Barbato L, Carrassi A, Discepoli N, Muti P J Orthop Traumatol. 2023; 24(1):36.

PMID: 37453950 PMC: 10349795. DOI: 10.1186/s10195-023-00713-7.


Pentoxifylline and tocopherol as prophylaxis for osteonecrosis of the jaw due to bone-modifying agents in patients with cancer submitted to tooth extraction: a case series.

Magalhaes J, da Motta Silveira F, Regueira L, de Lima E Silva D, de Andrade Veras S, de Mello M Support Care Cancer. 2023; 31(8):462.

PMID: 37436539 DOI: 10.1007/s00520-023-07906-0.